740
Views
48
CrossRef citations to date
0
Altmetric
Research Article

The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice

, , , , , , , , , , , , , & show all
Pages 117-125 | Received 03 Oct 2013, Accepted 07 Jan 2014, Published online: 13 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Monique Martins Melo, Fernanda Ferreira Cruz & Patricia Rieken Macedo Rocco. (2023) Mesenchymal stromal cell therapy for chronic lung diseases: experimental and clinical evidence. Expert Review of Respiratory Medicine 17:3, pages 223-235.
Read now
Maliheh Ghadiri, Paul M Young & Daniela Traini. (2016) Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease. Expert Opinion on Biological Therapy 16:3, pages 375-387.
Read now

Articles from other publishers (46)

Irena V. Chistyakova. (2023) Pulmonary fibrosis: risk factors, pathogenesis and in vivo/in vitro experimental modeling. Genes & Cells.
Crossref
Kuo-An Chu, Chang-Ching Yeh, Chun-Hsiang Hsu, Chien-Wei Hsu, Fu-Hsien Kuo, Pei-Jiun Tsai & Yu-Show Fu. (2023) Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells. International Journal of Molecular Sciences 24:8, pages 6948.
Crossref
Xiaoxi Lv, Shanshan Liu, Chang Liu, Yunxuan Li, Tingting Zhang, Jie Qi, Ke Li, Fang Hua, Bing Cui, Xiaowei Zhang, Yuxin Liu, Jiaojiao Yu, Jinmei Yu, Li Li, Xia Li, Zhigang Yao & Bo Huang. (2023) TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2. Acta Pharmaceutica Sinica B 13:4, pages 1631-1647.
Crossref
Bruna Benigna Sales Armstrong, Juan Carlos Montano Pedroso, José da Conceição CarvalhoJr.Jr. & Lydia Masako Ferreira. (2023) Mesenchymal stem cells in lung diseases and their potential use in COVID-19 ARDS: A systematized review. Clinics 78, pages 100237.
Crossref
Maryam Khajvand-Abedini, Mahdi Bahmani, Nasrin Ziamajidi, Alireza Nourian, Parisa Habibi, Shirin Heidarisasan & Roghayeh Abbasalipourkabir. (2022) The Restoring Effect of Human Umbilical Cord-Derived Mesenchymal Cell-Conditioned Medium (hMSC-CM) against Carbon Tetrachloride-Induced Pulmonary Fibrosis in Male Wistar Rats. International Journal of Inflammation 2022, pages 1-10.
Crossref
Zhihou GuoYaping ZhangFurong Yan. (2022) Potential of Mesenchymal Stem Cell-Based Therapies for Pulmonary Fibrosis. DNA and Cell Biology 41:11, pages 951-965.
Crossref
Takuya Kotani, Masaki Ikemoto, Shogo Matsuda, Ryota Masutani & Tohru Takeuchi. (2022) Human MIKO-1, a Hybrid Protein That Regulates Macrophage Function, Suppresses Lung Fibrosis in a Mouse Model of Bleomycin-Induced Interstitial Lung Disease. International Journal of Molecular Sciences 23:17, pages 9669.
Crossref
Alejandro Egea-Zorrilla, Laura Vera, Borja Saez & Ana Pardo-Saganta. (2022) Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis. Cells 11:16, pages 2595.
Crossref
Deng-Yuan Li, Ru-Fang Li, Dan-Xiong Sun, Dan-Dan Pu & Yun-Hui Zhang. (2021) Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies. Stem Cell Research & Therapy 12:1.
Crossref
Yan Li, Jian Zhang, Jihong Shi, Kaituo Liu, Xujie Wang, Yanhui Jia, Ting He, Kuo Shen, Yunchuan Wang, Jiaqi Liu, Wei Zhang, Hongtao Wang, Zhao Zheng & Dahai Hu. (2021) Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis. Stem Cell Research & Therapy 12:1.
Crossref
Gwenda F. Vasse, Lisette Van Os, Marina De Jager, Marnix R. Jonker, Theo Borghuis, L. Tim Van Den Toorn, Pytrick Jellema, Eric S. White, Patrick Van Rijn, Martin C. Harmsen, Irene H. Heijink, Barbro N. Melgert & Janette K. Burgess. (2021) Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices. Frontiers in Pharmacology 12.
Crossref
Raquel Guillamat-Prats. (2021) The Role of MSC in Wound Healing, Scarring and Regeneration. Cells 10:7, pages 1729.
Crossref
Anna Valeria Samarelli, Roberto Tonelli, Irene Heijink, Aina Martin Medina, Alessandro Marchioni, Giulia Bruzzi, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Linda Manicardi, Antonio Moretti, Stefania Cerri, Riccardo Fantini, Luca Tabbì, Chiara Nani, Ilenia Mastrolia, Daniel J. Weiss, Massimo Dominici & Enrico Clini. (2021) Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution. Frontiers in Pharmacology 12.
Crossref
Chiel van Geffen, Astrid Deißler, Markus Quante, Harald Renz, Dominik Hartl & Saeed Kolahian. (2021) Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?. Frontiers in Immunology 12.
Crossref
Sanghoon Park & Eun Joo Lee. (2021) Diagnosis and treatment of drug-induced interstitial lung disease. Journal of the Korean Medical Association 64:4, pages 286-295.
Crossref
Irene Rosa, Eloisa Romano, Bianca Saveria Fioretto, Marco Matucci-Cerinic & Mirko Manetti. (2021) Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis . World Journal of Stem Cells 13:1, pages 30-48.
Crossref
Mina Abedi, Sepideh Alavi-Moghadam, Moloud Payab, Parisa Goodarzi, Fereshteh Mohamadi-jahani, Forough Azam Sayahpour, Bagher Larijani & Babak Arjmand. (2020) Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives. Cell Regeneration 9:1.
Crossref
Youngjae Park, Yoon Jae Lee, Jung Hee Koh, Jennifer Lee, Hong-Ki Min, Moon Young Kim, Ki Joo Kim, Su Jin Lee, Jong Won Rhie, Wan-Uk Kim, Sung-Hwan Park, Suk-Ho Moon & Seung-Ki Kwok. (2020) Clinical Efficacy and Safety of Injection of Stromal Vascular Fraction Derived from Autologous Adipose Tissues in Systemic Sclerosis Patients with Hand Disability: A Proof-Of-Concept Trial. Journal of Clinical Medicine 9:9, pages 3023.
Crossref
Megan K. DeBari & Rosalyn D. Abbott. (2020) Adipose Tissue Fibrosis: Mechanisms, Models, and Importance. International Journal of Molecular Sciences 21:17, pages 6030.
Crossref
Sean D. McCarthyElizabeth HorganAreeba AliClaire MastersonJohn G. LaffeyRonan MacLoughlinDaniel O'Toole. (2020) Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:3, pages 140-152.
Crossref
Jason S. Rockel, Razieh Rabani & Sowmya Viswanathan. (2020) Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases. Seminars in Cell & Developmental Biology 101, pages 87-103.
Crossref
Eun Joo Lee, Nayra Cárdenes, Diana Álvarez, Jacobo Sellarés, John Sembrat, Paola Aranda, Yating Peng, Jordan Bullock, Seyed M. Nouraie, Ana L. Mora & Mauricio Rojas. (2019) Mesenchymal stem cells reduce ER stress via PERK‐Nrf2 pathway in an aged mouse model. Respirology 25:4, pages 417-426.
Crossref
Jing Wang, Yunjun Liao, Jing Xia, Zijue Wang, Xiaopei Mo, Jingwei Feng, Yunfan He, Xihang Chen, Ye Li, Feng Lu & Junrong Cai. (2019) Mechanical micronization of lipoaspirates for the treatment of hypertrophic scars. Stem Cell Research & Therapy 10:1.
Crossref
Mélanie VELIER, Stéphanie SIMONCINI, Maxime ABELLAN, Pauline FRANCOIS, Sandy EAP, Anaïs LAGRANGE, Baptiste BERTRAND, Aurélie DAUMAS, Brigitte GRANEL, Bruno DELORME, Françoise DIGNAT GEORGE, Jérémy MAGALON & Florence SABATIER. (2019) Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro. Journal of Clinical Medicine 8:11, pages 1979.
Crossref
Shan-shan Liu, Xiao-xi Lv, Chang Liu, Jie Qi, Yun-xuan Li, Xu-peng Wei, Ke Li, Fang Hua, Bing Cui, Xiao-wei Zhang, Jiao-jiao Yu, Jin-mei Yu, Feng Wang, Shuang Shang, Chen-xi Zhao, Xue-ying Hou, Zhi-gang Yao, Ping-ping Li, Xia Li, Bo Huang & Zhuo-wei Hu. (2019) Targeting Degradation of the Transcription Factor C/EBPβ Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages. Immunity 51:3, pages 522-534.e7.
Crossref
Aurora Almadori, Michelle Griffin, Caroline M. Ryan, Debbie F. Hunt, Esther Hansen, Ravi Kumar, David J. Abraham, Christopher P. Denton & Peter E. M. Butler. (2019) Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. PLOS ONE 14:7, pages e0218068.
Crossref
Alexander Rühle, Ramon Lopez Perez, Bingwen Zou, Anca-Ligia Grosu, Peter E. Huber & Nils H. Nicolay. (2019) The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage. Stem Cell Reviews and Reports 15:3, pages 356-373.
Crossref
Chi‐Yung Chai, Junlong Song, Zhenwei Tan, I‐Chun Tai, Chaoying Zhang & Shengrong Sun. (2018) Adipose tissue‐derived stem cells inhibit hypertrophic scar (HS) fibrosis via p38/MAPK pathway. Journal of Cellular Biochemistry 120:3, pages 4057-4064.
Crossref
Janette K. Burgess, Kirsten Muizer, Corry-Anke Brandsma & Irene H. Heijink. 2019. Fibrosis in Disease. Fibrosis in Disease 239 270 .
Pauline Rozier, Alexandre Maria, Radjiv Goulabchand, Christian Jorgensen, Philippe Guilpain & Danièle Noël. (2018) Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?. Frontiers in Immunology 9.
Crossref
XiaoSan Su, Liu Yang, YanFeng Yin, Jie Huang, Fei Qiao, Yu Fang, Lu Yu, YinYin Wang, KaiHua Zhou & Jun Wang. (2018) Bone marrow mesenchymal stem cells tune the differentiation of myeloid-derived suppressor cells in bleomycin-induced lung injury. Stem Cell Research & Therapy 9:1.
Crossref
Anna Serrano-Mollar. (2018) Cell Therapy in Idiopathic Pulmonary Fibrosis†. Medical Sciences 6:3, pages 64.
Crossref
Argyrios Tzouvelekis, Rebecca Toonkel, Theodoros Karampitsakos, Kantha Medapalli, Ioanna Ninou, Vasilis Aidinis, Demosthenes Bouros & Marilyn K. Glassberg. (2018) Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 5.
Crossref
Pedro Llontop, Daniel Lopez-Fernandez, Bernardino Clavo, Juan Luis Afonso Martín, María D Fiuza-Pérez, Mariano García Arranz, Joaquín Calatayud, Laureano Molins López-Rodó, Khalid Alshehri, Adil Ayub, Wissam Raad, Faiz Bhora & Norberto Santana-Rodríguez. (2023) Airway Transplantation of Adipose Stem Cells Protects against Bleomycin-Induced Pulmonary Fibrosis. Journal of Investigative Medicine 66:4, pages 739-746.
Crossref
Jingcheng DengYuan ShiZhen GaoWenjie ZhangXiaoli WuWeigang CaoWei Liu. (2018) Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells. Tissue Engineering Part A 24:5-6, pages 382-393.
Crossref
Michelle Griffin, Caroline M. Ryan, Omar Pathan, David Abraham, Christopher P. Denton & Peter E. M. Butler. (2017) Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine. Stem Cell Research & Therapy 8:1.
Crossref
Takuya Kotani, Ryota Masutani, Takayasu Suzuka, Katsuhiro Oda, Shigeki Makino & Masaaki Ii. (2017) Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia. Scientific Reports 7:1.
Crossref
Katrin E. Hostettler, Amiq Gazdhar, Petra Khan, Spasenija Savic, Luca Tamo, Didier Lardinois, Michael Roth, Michael Tamm & Thomas Geiser. (2017) Multipotent mesenchymal stem cells in lung fibrosis. PLOS ONE 12:8, pages e0181946.
Crossref
Jun Tashiro, Gustavo A. Rubio, Andrew H. Limper, Kurt Williams, Sharon J. Elliot, Ioanna Ninou, Vassilis Aidinis, Argyrios Tzouvelekis & Marilyn K. Glassberg. (2017) Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 4.
Crossref
Nicoletta Del Papa, Eleonora Zaccara, Gabriele Di Luca, Romina Andracco, Wanda Maglione & Claudio Vitali. (2016) Adipose-Derived Cell Transplantation in Systemic Sclerosis: State of the Art and Future Perspectives. Journal of Scleroderma and Related Disorders 2:1, pages 33-41.
Crossref
Yan Li, Wei Zhang, Jianxin Gao, Jiaqi Liu, Hongtao Wang, Jun Li, Xuekang Yang, Ting He, Hao Guan, Zhao Zheng, Shichao Han, Maolong Dong, Juntao Han, Jihong Shi & Dahai Hu. (2016) Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway. Stem Cell Research & Therapy 7:1.
Crossref
Anandharajan Rathinasabapathy, Erin Bruce, Andrew Espejo, Alana Horowitz, Dhivya R Sudhan, Anand Nair, Dominic Guzzo, Joseph Francis, Mohan K Raizada, Vinayak Shenoy & Michael J Katovich. (2016) Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis. British Journal of Pharmacology 173:19, pages 2859-2879.
Crossref
Nadim Srour & Bernard Thébaud. (2015) Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review. Stem Cells Translational Medicine 4:12, pages 1500-1510.
Crossref
Brigitte Granel, Aurélie Daumas, Elisabeth Jouve, Jean-Robert Harlé, Pierre-Sébastien Nguyen, Christian Chabannon, Nathalie Colavolpe, Jean-Charles Reynier, Romain Truillet, Stéphanie Mallet, Antoine Baiada, Dominique Casanova, Laurent Giraudo, Laurent Arnaud, Julie Veran, Florence Sabatier & Guy Magalon. (2015) Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Annals of the Rheumatic Diseases 74:12, pages 2175-2182.
Crossref
Jun Tashiro, Sharon J. Elliot, David J. Gerth, Xiaomei Xia, Simone Pereira-Simon, Rhea Choi, Paola Catanuto, Shahriar Shahzeidi, Rebecca L. Toonkel, Rahil H. Shah, Fadi El Salem & Marilyn K. Glassberg. (2015) Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Translational Research 166:6, pages 554-567.
Crossref
Marek Barczyk, Matthias Schmidt & Sabrina Mattoli. (2015) Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis. Stem Cell Reviews and Reports 11:4, pages 598-620.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.